Dean Ron Jordan of Chapman University School of Pharmacy (CUSP) is pleased to announce that the National Institute of Health has awarded $400,000 to Dr. Kamaljit Kaur for her work in breast cancer treatment. Dr. Kaur, Associate Professor in Targeted Drug Delivery and Biomedical Diagnostics at CUSP, will continue her research in targeting peptides for improved efficacy of current cancer treatment. The project’s success will directly impact women’s health and will ultimately increase cancer patient survival.

Chapman University and the entire CUSP team are proud to celebrate Dr. Kaur’s tremendous achievement and commitment to “helping people live healthier, better lives!”